Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer
Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
In the Lab
MSK-led Studies Support the Concept of “Cancer Environment Immunotherapy”
Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.
At Work: Immunologist Ming Li
Immunologist Ming Li hopes to uncover insights that would allow scientists to harness the power of the immune system for cancer therapy.
Feature
After Years of Neglect, Cancer Biologists Return to a Forgotten Field: Metabolism
Scientists are dusting off their biochemistry textbooks in the hunt for clues to cancer.
Q&A
No Sugar, No Cancer? A Look at the Evidence
A lot has been written about the relationship between sugar and cancer. Most of it is wrong.
Science Byte
The Warburg Effect: What Turns T Cells On?
Scientists have uncovered a surprising link between metabolism and gene control in T cells.
In the Lab
Researchers Reveal How Tumors Manipulate Certain Immune Cells to Their Own Advantage
Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.
In the Lab
In the Fight against Cancer, the Immune System Can Be a Double-Edged Sword
The immune system is a powerful tool for fighting cancer — sometimes too powerful.
Q&A
Study Suggests New Ways of Manipulating Immune System to Treat Autoimmune Diseases and Cancer
Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.
